Downloadable Nitrosamine Risk Assessment Template: What Every Pharmaceutical Company Needs
Pharmaceutical companies worldwide are under increasing regulatory pressure to assess, mitigate, and report the risk of nitrosamine impurities in drug […]
Case Study: How Our Analytical Development Laboratory Accelerated a Peptide NDA Filing
In today’s competitive pharmaceutical landscape, speed and precision in regulatory filings can determine a product’s commercial success. At ResolveMass Laboratories
Case Study: How Our Analytical Development Laboratory Accelerated a Peptide NDA Filing Read More »
Accelerating Quality Control: How GC-MS Method Development Services Support Regulatory Compliance in Canada and the United States
In the highly regulated pharmaceutical and chemical industries, regulatory compliance is not optional—it’s a legal, ethical, and scientific obligation. With
Mastering Precision: How LC-MS/MS Method Development Services Accelerate Drug Discovery in Canada and the U.S.
Liquid Chromatography with Tandem Mass Spectrometry (LC-MS/MS) has become a transformative tool in drug discovery and pharmaceutical analysis. Its precision,
How to Choose the Right Protein Quantification Lab in Montreal & Beyond
Protein quantification is a cornerstone of biomedical research, biopharmaceutical manufacturing, diagnostics, and clinical development. From evaluating drug efficacy to monitoring
How to Choose the Right Protein Quantification Lab in Montreal & Beyond Read More »
Trace-Level PFAS Testing with LC-MS/MS: A Case Study on Consumer Product Packaging
Introduction The presence of per- and polyfluoroalkyl substances (PFAS) in consumer products has become a critical concern in public health
Trace-Level PFAS Testing with LC-MS/MS: A Case Study on Consumer Product Packaging Read More »
Best CRO Services for Identification of an Unknown Impurity in Canada and the U.S.
Introduction: Why You Need the Right CRO for Unknown Impurity Identification In the pharmaceutical lifecycle, encountering an unexpected impurity—especially during
Best CRO Services for Identification of an Unknown Impurity in Canada and the U.S. Read More »
How We Carried Out Identification of an Unknown Impurity in a Phase 3 API Using LC-MS/MS & NMR
Introduction: Why Identification of an Unknown Impurity is Critical in Phase 3 Drug Development In late-stage pharmaceutical development, identification of
Peptide Characterization Case Study: Identifying Sequence Impurities in a GLP-1 Analog
Introduction: The Role of Peptide Characterization in GLP-1 Analog Therapeutics In the development and QC stages of GLP-1 receptor agonists,
Peptide Characterization Case Study: Identifying Sequence Impurities in a GLP-1 Analog Read More »
E&L Testing CRO Case Study: Mitigating Leachables Risk in a Biologic Vial System
Introduction: Why Addressing Leachables Risk in a Biologic Vial System is Crucial In 2025, the biopharmaceutical industry continues to face
E&L Testing CRO Case Study: Mitigating Leachables Risk in a Biologic Vial System Read More »